Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Endometrial Injury and IVF-ET Outcome

This study has been completed.
Information provided by:
Bangalore Assisted Conception Centre Identifier:
First received: November 21, 2008
Last updated: December 1, 2008
Last verified: November 2008
Implantation of the human embryo is the limiting factor in the success of invitro-fertilization and embryo transfer(IVF-ET).We wanted to find out whether creating a local injury to the endometrium in the non-transfer cycle would improve the IVF-ET outcome in the subsequent cycle.We believe that the injury created causes release of substances which help in implantation.

Condition Intervention

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Does Endometrial Injury in the Non-Transfer Cycle Improve the IVF-ET Outcome in the Subsequent Cycle in Patients With Previous Failed IVF Cycles: A Randomized Control Trial

Further study details as provided by Bangalore Assisted Conception Centre:

Primary Outcome Measures:
  • PRIMARY OUTCOME MEASURE:IMPLANTATION RATE; [ Time Frame: 9 MONTHS ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • CLINICAL PREGNANCY RATE,ONGOING PREGNANCY RATE [ Time Frame: 9 MONTHS ] [ Designated as safety issue: No ]

Enrollment: 99
Study Start Date: November 2007
Study Completion Date: September 2008
Primary Completion Date: September 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Pipelle endometrial sampling will be done twice between 7th to 10th day and 24th to 26th d in the cycle prior to IVF.
Other Name: Endometrial sampling
No Intervention: 2

Detailed Description:

Study Design and Subjects: This is a randomized control study designed to evaluate the effect of local injury to the endometrium in non-transfer cycle in patients with previous failed IVF.

Patients will be randomly allotted to control and intervention group The patients in the intervention group Pipelle endometrial sampling 7-10th day and 24-26th day in the cycle prior to IVF transfer cycle.

Outcome Measures: Clinical pregnancy rate,implantation rate and ongoing pregnancy rate.

SAMPLE SIZE: 100 PATIENTS (50 in each group).


Ages Eligible for Study:   18 Years to 37 Years   (Adult)
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Previous failed In-vitro fertilization embryo transfer cycle
  • Patients who are good responders and have good quality embryos in the previous attempts
  • Age of patients upto 37yrs

Exclusion Criteria:

  • Those detected to have endometrial tuberculosis in the past, including those treated with Antituberculosis treatment
  • Those with intramural fibroid distorting the endometrial cavity/sub-mucous myoma
  • Those with sonographically detected hydrosalpinx
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00796341

Bangalore Assisted Conception Centre
Bangalore, Karnataka, India, 560001
Sponsors and Collaborators
Bangalore Assisted Conception Centre
Principal Investigator: SACHIN A NARVEKAR, MD Bangalore Assisted Conception Centre
  More Information

Responsible Party: Dr Kamini A Rao, Bangalore Assisted Conception Centre Identifier: NCT00796341     History of Changes
Other Study ID Numbers: endometrial injury study 
Study First Received: November 21, 2008
Last Updated: December 1, 2008
Health Authority: India: Institutional Review Board

Keywords provided by Bangalore Assisted Conception Centre:
invitro-fertilization ,embryo transfer,endometrial injury

Additional relevant MeSH terms:
Genital Diseases, Male
Genital Diseases, Female processed this record on January 14, 2017